Blessie Nelson

14PUBLICATIONS
37CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsRadiation therapyImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 11, 2025
Phase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of Clostridium novyi-NT in Patients with Advanced Solid Tumors.

Blessie Elizabeth Nelson, Filip Janku, Siqing Fu

|Jan 17, 2025
Phase I study of BMS-986299, an NLRP3 agonist, as monotherapy and in combination with nivolumab and ipilimumab in patients with advanced solid tumors.

Blessie E Nelson, Shaun O'Brien, Rahul A Sheth

|Jun 13, 2023
A Phase I Trial of Bevacizumab and Temsirolimus in Combination With Valproic Acid in Advanced Solid Tumors.

Blessie Elizabeth Nelson, Apostolia M Tsimberidou, Xueyao Fu

|Jun 01, 2023
Predicting the Abscopal Effect: Associated Tumor Histologic Subtypes and Biomarkers.

Blessie Elizabeth Nelson, Jacob J Adashek, Aakash Akshay Sheth

|May 25, 2023
Histological transformation to gliosarcoma with combined BRAF/MEK inhibition in BRAF V600E mutated glioblastoma.

Blessie Elizabeth Nelson, Neha K Reddy, Jason T Huse

|Apr 16, 2023
Tumor-Agnostic Precision Medicine from the AACR GENIE Database: Clinical Implications.

Mohamed A Gouda, Blessie E Nelson, Lars Buschhorn

Pageof 3

Frequent Collaborators

6 joint publications

Vivek Subbiah

4 joint publications

Aung Naing

3 joint publications

Sarina A Piha-Paul

3 joint publications

Apostolia Tsimberidou